Metraipolis › archive › dc_4072a3f2e704

A Tumor-Agnostic, Topology-Informed Scoring Framework for Drug Repurposing: Application to CDK4/6 Inhibitor Resistance in HR+ Breast Cancer — Europe PMC PMID:41898239

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41898239
DOI
10.3390/biomedicines14030592
License (as archived)
solo-consultazione
Archived
2026-10-07T21:47:08.837Z
SHA-256 of the archived text
96e79b0bdeec5cf3686d01a05e95e21fdff7579149981d1b1fdf27409251749d
Stable URL of this page
https://metraipolis.com/documento/dc_4072a3f2e704

How to cite

A Tumor-Agnostic, Topology-Informed Scoring Framework for Drug Repurposing: Application to CDK4/6 Inhibitor Resistance in HR+ Breast Cancer — Europe PMC PMID:41898239 — Europe PMC (en), https://europepmc.org/article/MED/41898239 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4072a3f2e704 (Metraipolis archive dc_4072a3f2e704, sha256 96e79b0bdeec5cf3686d01a05e95e21fdff7579149981d1b1fdf27409251749d)
BibTeX
@misc{dc4072a3f2e704,
  title = {A Tumor-Agnostic, Topology-Informed Scoring Framework for Drug Repurposing: Application to CDK4/6 Inhibitor Resistance in HR+ Breast Cancer — Europe PMC PMID:41898239},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41898239},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4072a3f2e704; sha256 96e79b0bdeec5cf3686d01a05e95e21fdff7579149981d1b1fdf27409251749d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41898239. Agents can read the archived copy with the MCP tool read_document.